Purchase Order 75N95022P00410

This firm fixed price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to Integrated DNA Technologies, Inc. for $701,584. The contract calls for the synthesis of 13,492 antisense oligonucleotides in support of an ongoing SARS-CoV-2 study for the NIH National Institute on Drug Abuse. As the incumbent contractor, Integrated DNA Technologies previously synthesized the oligonucleotides...

The Centers for Disease Control and Prevention (CDC) awarded a $249,445 firm-fixed-price purchase order to Integrated DNA Technologies, Inc. (IDT) to provide oligonucleotides and gene production in support of the development of COVID-19 vaccine candidates. The award does not have a set-aside designation. IDT is a major provider of specialized nucleic acid products and services to federal agencies, including the NIH, CDC, DoD, and USDA, through prime contracts and subcontracts. The company...

This is a firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Eurofins Genomics LLC, a for-profit manufacturer of goods, to produce oligonucleotides for the CDC's Rapid Production of Oligonucleotides for Circulating Vaccine-Derived Poliovirus (OLIGO CVV RAPID PRODUCTION) program. The contract has a ceiling value of $171,193.00 and a period of performance ending on September 25, 2025. The contract does not have a set-aside designation. Eurofins...

The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences (NCATS) awarded a firm fixed price purchase order to Integrated DNA Technologies, Inc. (IDT) for the custom synthesis of 1,536 antisense oligonucleotides targeting the CHCHD10 gene. The $102,915.50 contract has an August 29, 2022 completion date and does not have a set-aside designation. IDT is a manufacturer of nucleic acid products that has previously supported...

This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Twist Bioscience Corporation, a synthetic biology company based in South San Francisco, California. The $97,588 contract is for the provision of COVID-19 DNA constructs, which likely support genomics research, disease surveillance, and public health initiatives. This contract does not have a set-aside designation. Twist...

The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price delivery order contract to Biosearch Technologies, Inc. LGC Biosearch Technologies Division. The $787,500.00 contract, which has no set-aside designation, is for the provision of oligonucleotide-based laboratory supplies such as primer probes, assay kits, PCR kits, and oligonucleotides. These products support the CDC's disease surveillance, diagnostic testing, public health research,...

This is a $236,603.20 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC), which is part of the Department of Health and Human Services, to Biosearch Technologies, Inc. The award is for the provision of RUO (Research Use Only) oligonucleotides. Biosearch Technologies is a manufacturer of oligonucleotide-based tools, including fluorophores and dark quenchers, and has previously provided laboratory supplies such as primer probes, assay kits, PCR kits,...

The National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $702,500 firm-fixed-price contract to Genscript USA Inc. to provide gene synthesis services in support of COVID-19 testing. Under the contract, Genscript will synthesize 150 genes and conduct 150 mutagenesis and 250 express cloning projects, as well as prepare 425 plasmids. These products and services will support the testing of COVID-19 antibody therapeutics, convalescent plasma, and vaccines...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $150,355.40 firm fixed price purchase order contract to Genscript USA Inc., a biotechnology company, for COVID-19 research services. The contract includes DNA synthesis, cloning, plasmid preparation, and antibody expression and purification to support the Vaccine Research Center's continued COVID-19 studies. The services are to be performed at the NIH facility...

This federal contract award to Biosearch Technologies, Inc. LGC Biosearch Technologies Division, a privately held manufacturer of oligonucleotide-based tools, is for the provision of primers and probes. The $127,000.00 firm fixed price purchase order was issued by the Centers for Disease Control and Prevention (CDC) to support disease surveillance, diagnostic testing, public health research, and emergency response efforts related to pathogens such as influenza, COVID-19, Ebola, and Brucella....